News about "Zydus Lifesciences"

Zydus's Chairman Pankaj R Patel Conferred with Padma Bhushan

With a Masters in Pharmaceutics and Pharmaceutical Technology from the L.M. College of Pharmacy and an alumni of the Indian Institute of Management (IIM), Ahmedabad, he was always driven by a passion to become a pharma entrepreneur.

Zydus Lifesciences | 27/01/2025 | By Aishwarya

Zydus Signs Licensing and Supply Agreement with Viwit Pharmaceuticals

As per the terms of the agreement, Viwit will be responsible for ANDA submission, manufacturing and supplying the generic versions of GADAVISTTM and DOTAREM, following the receipt of requisite regulatory approval.

Zydus Lifesciences | 16/09/2024 | By Aishwarya |  109

Zydus Gets Final Approval from USFDA for Scopolamine Transdermal System

Scopolamine Transdermal System is indicated to prevent nausea and vomiting after anaesthesia, narcotic pain medicines, and surgery.

Zydus Lifesciences | 31/08/2024 | By Aishwarya |  102

Zydus Gets Approval from COFEPRIS to Market Mamitra

Zydus Lifesciences has announced that COFEPRIS (Federal Commission for the Protection Against Sanitary Risk) has granted marketing approval for Mamitra, a Trastuzumab biosimilar.

Zydus Lifesciences | 31/07/2024 | By Aishwarya

Zydus Gets Tentative Approval from USFDA for Azilsartan Medoxomil Tablets

Zydus Lifesciences Ltd. has secured a tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil Tablets, 40 mg and 80 mg (USRLD: Edarbi tablets).

Zydus Lifesciences | 06/07/2024 | By Aishwarya |  199

Zydus and Dr. Reddy to Co-Market Pertuzumab Biosimilar in India

Zydus Lifesciences and Dr. Reddy’s Laboratories Ltd. have announced the execution of a licensing agreement to co-market Pertuzumab biosimilar in India.

Zydus Lifesciences | 05/07/2024 | By Aishwarya |  513

Zydus Completes Enrolment for EPICS IIITM Phase 2b/3 Trial of Saroglitazar Mg

Zydus Lifesciences has completed enrolment of Phase 2b/3 EPICS IIITM trial of Saroglitazar Mg in patients with Primary Biliary Cholangitis (PBC).

Zydus Lifesciences | 10/05/2024 | By Aishwarya |  183

Sentynl Therapeutics Completes Acquisition of Eiger BioPharmaceuticals' Zokinvy Program

Zokinvy is the first and only treatment approved by the US Food and Drug Administration (FDA) for Hutchinson-Gilford progeria syndrome (HGPS) and processing-deficient progeroid laminopathies (PDPL).

Zydus Lifesciences | 04/05/2024 | By Abha |  228

Bayer Acquires Zydus Pharma with Full Ownership

Bayer Pharmaceuticals Private Ltd. and Zydus Lifesciences Ltd. have announced the successful conclusion of their joint venture (JV) - Bayer Zydus Pharma Private Ltd. (BZPPL).

Zydus Lifesciences | 03/05/2024 | By Aishwarya |  143

Zydus receives final approval from the USFDA for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg

Zydus receives final approval from the USFDA for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg

Zydus Lifesciences | 09/06/2023 | By Sudeep Soparkar |  188